Abstract:Regulation of therapeutic protein expression by ultrashort peptides. In this engineered mammalian cell system, an ultrashort peptide receptor in the outer membrane detects inducers. Activation of the receptor triggers a signal cascade, leading to expression and secretion of the protein‐of‐interest. Encapsulated cells implanted in mice implement this mechanism, regulating therapeutic protein production, offering targeted treatment for specific diseases. Despite the array of mammalian transgene switches available for regulating therapeutic protein expression in response to small molecules or physical stimuli, issues remain, including cytotoxicity of chemical inducers and limited biocompatibility of physical cues. This study introduces gene switches driven by short peptides comprising eight or fewer amino acid residues. Utilizing a competence regulator (ComR) and sigma factor X‐inducing peptide (XIP) from Streptococcus vestibularis as the receptor and inducer, respectively, this study develops two strategies for a peptide‐activated transgene control system. The first strategy involves fusing ComR with a transactivation domain and utilizes ComR‐dependent synthetic promoters to drive expression of the gene‐of‐interest, activated by XIP, thereby confirming its membrane penetrability and intracellular functionality. The second strategy features an orthogonal synthetic receptor exposing ComR extracellularly (ComREXTRA), greatly increasing sensitivity with exceptional responsiveness to short peptides. In a proof‐of‐concept study, peptides are administered to type‐1 diabetic mice with microencapsulated engineered human cells expressing ComREXTRA for control of insulin expression, restoring normoglycemia. It is envisioned that this system will encourage the development of short peptide drugs and promote the introduction of non‐toxic, orthogonal, and highly biocompatible personalized biopharmaceuticals for gene‐ and cell‐based therapies.

Aptamer‐Array‐Guided Protein Assembly Enhances Synthetic mRNA Switch Performance

Self-feedback loop-containing synthetic mRNA switches for controlled microRNA sensing

Orthogonal Protein-Responsive mRNA Switches for Mammalian Synthetic Biology

Split RNA switch: Programmable and precise control of gene expression by ensemble of pre- and post-translational regulation

Aptamer-Based Switching System for Communication of Non-Interacting Proteins

Small-molecule-based regulation of RNA-delivered circuits in mammalian cells

Rational Design of Aptazyme Riboswitches for Efficient Control of Gene Expression in Mammalian Cells

Y-switch: a spring-loaded synthetic gene switch for robust DNA/RNA signal amplification and detection

A Reversible RNA On-Switch That Controls Gene Expression of AAV-delivered Therapeutics in Vivo

Synthetic circular RNA switches and circuits that control protein expression in mammalian cells

Rational Construction of Protein-Mimetic Nano-Switch Systems Based on Secondary Structure Transitions of Synthetic Polypeptides

Establishing Artificial Gene Connections Through RNA Displacement–assembly-Controlled CRISPR/Cas9 Function

Switching the activity of Taq polymerase using clamp-like triplex aptamer structure

Development of epistatic YES and AND protein logic gates and their assembly into signalling cascades

Toehold-Exchange-Based Activation of Aptamer Switches Enables High Thermal Robustness and Programmability

Dual Input-Controlled Synthetic mRNA Circuit for Bidirectional Protein Expression Regulation

Conditional Regulation of Gene Expression by Ligand-Induced Occlusion of a MicroRNA Target Sequence.

Small-Molecule Modulated Affinity-Tunable Semisynthetic Protein Switches

Ultrashort‐Peptide‐Responsive Gene Switches for Regulation of Therapeutic Protein Expression in Mammalian Cells

Aptamers, Riboswitches, and Ribozymes in S. cerevisiae Synthetic Biology

Controlled Protein Assembly On A Switchable Surface